Literature DB >> 28389991

Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I.

Ahmed Mosaeilhy1, Magdy M Mohamed2, George Priya Doss C3, Heba S A El Abd1, Radwa Gamal1, Osama K Zaki4,5, Hatem Zayed6.   

Abstract

Glutaric acidemia I (GAI) is an autosomal recessive metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (GCDH). Patients with GAI are characterized by macrocephaly, acute encephalitis-like crises, dystonia and frontotemporal atrophy. In this study, we investigated 18 Egyptian patients that were diagnosed with GAI based on their clinical, neuroradiological, and biochemical profiles. Of the 18 patients, 16 had developmental delay and/or regression, dystonia was prominent in 75% of the cases, and three patients died. Molecular genetics analysis identified 14 different mutations in the GCDH gene in the 18 patients, of the 14 mutations, nine were missense, three were in the 3'-Untranslated Region (3'-UTR), one was nonsense, and one was a silent mutation. Four novel mutations were identified (c.148 T > A; p.Trp50Arg, c.158C > A; p.Pro53Gln, c.1284C > G; p.Ile428Met, and c.1189G > T; p.Glu397*) that were all absent in 300 normal chromosomes. The 3'-UTR mutation (c.*165A > G; rs8012), was the most frequent mutation observed (0.5; 18/36), followed by the most common mutation among Caucasian patients (p.Arg402Trp; rs121434369) with allele frequency of 0.36 (13/36), and the 3'-UTR mutation (c.*288G > T; rs9384, 0.22; 8/16). The p.Arg257Gln mutation was found with allele frequency of ~0.17 (6/36). The marked homozygosity observed in our patients is probably due to the high level of consanguinity that is observed in 100% of the cases. We used nine in silico prediction tools to predict the pathogenicity (SIFT, PhD-SNP, SNAP, Meta-SNP, PolyPhen2, and Align GVGD) and protein stability (I-Mutant2.0, Mupro, and istable) of the nine missense mutants. The mutant p.Arg402Trp was predicted to be most deleterious by all the six pathogenicity prediction tools and destabilizing by all the three-stability prediction tools, and highly conserved by the ConSurf server. Using the clinical, biochemical, family history of the 18 patients, and the in silico analysis of the missense mutations, our study showed a mix of conclusive and inconclusive genotype-phenotype correlations among our patient's cohort and suggests the usefulness of using various sophisticated computational analysis to be utilized for future variant classifications in the genetic clinics.

Entities:  

Keywords:  Computational analysis; Egypt; Genotype-phenotype correlation; Glutaric acidemia type I; Glutaryl-CoA dehydrogenase; Organic acidemia; Variant assessment

Mesh:

Substances:

Year:  2017        PMID: 28389991     DOI: 10.1007/s11011-017-0006-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  42 in total

1.  ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information.

Authors:  Fabian Glaser; Tal Pupko; Inbal Paz; Rachel E Bell; Dalit Bechor-Shental; Eric Martz; Nir Ben-Tal
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

2.  Use of guidelines improves the neurological outcome in glutaric aciduria type I.

Authors:  Jana Heringer; S P Nikolas Boy; Regina Ensenauer; Birgit Assmann; Johannes Zschocke; Inga Harting; Thomas Lücke; Esther M Maier; Chris Mühlhausen; Gisela Haege; Georg F Hoffmann; Peter Burgard; Stefan Kölker
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

3.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

4.  Molecular analysis of Cypriot patients with Glutaric aciduria type I: identification of two novel mutations.

Authors:  Theodoros Georgiou; Paola Nicolaidou; Anastasia Hadjichristou; Rodothea Ioannou; Maria Dionysiou; Elli Siama; Georgia Chappa; Violetta Anastasiadou; Anthi Drousiotou
Journal:  Clin Biochem       Date:  2014-06-25       Impact factor: 3.281

5.  Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency.

Authors:  Stefan Kölker; Sven F Garbade; Cheryl R Greenberg; James V Leonard; Jean-Marie Saudubray; Antonia Ribes; H Serap Kalkanoglu; Allan M Lund; Begoña Merinero; Moacir Wajner; Mónica Troncoso; Monique Williams; John H Walter; Jaume Campistol; Milagros Martí-Herrero; Melissa Caswill; Alberto B Burlina; Florian Lagler; Esther M Maier; Bernd Schwahn; Aysegul Tokatli; Ali Dursun; Turgay Coskun; Ronald A Chalmers; David M Koeller; Johannes Zschocke; Ernst Christensen; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

6.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.

Authors:  S V Tavtigian; A M Deffenbaugh; L Yin; T Judkins; T Scholl; P B Samollow; D de Silva; A Zharkikh; A Thomas
Journal:  J Med Genet       Date:  2005-07-13       Impact factor: 6.318

7.  Severe neurological manifestations in an Egyptian patient with a novel frameshift mutation in the Glutaryl-CoA dehydrogenase gene.

Authors:  Ahmed Moseilhy; Magdy M Hassan; Heba S A El Abd; Shaimaa A Mohammad; Rajaa El Bekay; Ussama M Abdel-Motal; Allal Ouhtit; Osama K Zaki; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2016-08-01       Impact factor: 3.584

8.  Mutation analysis in glutaric aciduria type I.

Authors:  J Zschocke; E Quak; P Guldberg; G F Hoffmann
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

9.  Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome.

Authors:  Avihu Boneh; Miriam Beauchamp; Maureen Humphrey; Jemma Watkins; Heidi Peters; Joy Yaplito-Lee
Journal:  Mol Genet Metab       Date:  2008-04-14       Impact factor: 4.797

10.  SNAP: predict effect of non-synonymous polymorphisms on function.

Authors:  Yana Bromberg; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  14 in total

1.  Two Uneventful Pregnancies in a Woman with Glutaric Aciduria Type 1.

Authors:  Karolina M Stepien; Gregory M Pastores; Una Hendroff; Ciara McCormick; Patricia Fitzimons; Naveed Khawaja; Ingrid Borovickova; Eileen P Treacy
Journal:  JIMD Rep       Date:  2018-01-03

2.  Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.

Authors:  C George Priya Doss; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2017-09-06       Impact factor: 3.584

3.  Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach.

Authors:  Ashish Kumar Agrahari; Meghana Muskan; C George Priya Doss; R Siva; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-05-27       Impact factor: 3.584

4.  A profound computational study to prioritize the disease-causing mutations in PRPS1 gene.

Authors:  Ashish Kumar Agrahari; P Sneha; C George Priya Doss; R Siva; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2017-10-18       Impact factor: 3.584

5.  Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.

Authors:  D Thirumal Kumar; Hend Ghasan Eldous; Zainab Alaa Mahgoub; C George Priya Doss; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-06       Impact factor: 3.584

6.  Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach.

Authors:  P Sneha; Tanzila U Zenith; Ummay Salma Abu Habib; Judith Evangeline; D Thirumal Kumar; C George Priya Doss; R Siva; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-13       Impact factor: 3.584

7.  Glutaric Aciduria Type 1: A Case Report and Review of Literature.

Authors:  Sidaraddi Sanju; Milind S Tullu; Nithya Seshadri; Mukesh Agrawal
Journal:  J Pediatr Intensive Care       Date:  2020-04-17

8.  Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.

Authors:  D Thirumal Kumar; L Jerushah Emerald; C George Priya Doss; P Sneha; R Siva; W Charles Emmanuel Jebaraj; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-09       Impact factor: 3.655

9.  Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1.

Authors:  Hatem Zayed; Hamed El Khayat; Hoda Tomoum; Ola Khalifa; Ehab Siddiq; Shaimaa A Mohammad; Radwa Gamal; Zumin Shi; Ahmed Mosailhy; Osama K Zaki
Journal:  Metab Brain Dis       Date:  2019-05-06       Impact factor: 3.584

10.  Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients From China.

Authors:  Huishu E; Lili Liang; Huiwen Zhang; Wenjuan Qiu; Jun Ye; Feng Xu; Zhuwen Gong; Xuefan Gu; Lianshu Han
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.